Table 2.
Multivariate survival analysis in 514 ovarian cancer patients from the TCGA Affymetrix dataset.
| Variable | Progression Free Survival | Overall Survival | |||||
|---|---|---|---|---|---|---|---|
| RR | (95 CI) | p Value | RR | (95 CI) | p Value | ||
| Age | ≤ 50.0 yrs > | 0.93 | (0.83–1.05) | 0.252 | 1.02 | (0.95–1.11) | 0.541 |
| FIGO stage | I/II vs. III/IV | 2.02 | (1.38–2.97) | <0.001 | 1.14 | (0.10–1.31) | 0.060 |
| Tumour grade | 1/2 vs. 3 | 0.98 | (0.89–1.09) | 0.755 | 1.02 | (0.94–1.11) | 0.621 |
| Residual disease after surgery | no vs. Yes | 1.07 | (0.96–1.20) | 0.204 | 1.02 | (0.92–1.14) | 0.710 |
| RANKL mRNA expression | low vs. high | 1.32 | (1.04–1.68) | 0.022 | 1.26 | (1.00–1.57) | 0.046 |
| Note: The significance level (p) was determined by Cox regression. Abbreviations: CI, confidence interval; RR, relative risk. | |||||||